Psoriasis disease severity affects patient satisfaction with treatment.
Patients with psoriasis are often dissatisfied with available treatments, but contributing factors are not well defined. Examine relationships between psoriasis severity, patient characteristics, and treatment satisfaction. Patients with psoriasis were classified into mild and moderate-to-severe groups based on self-reported data. Demographics, comorbidities, symptoms, and multiple treatment satisfaction outcomes were compared between groups. Predictors of patient satisfaction with treatment were examined using linear regression models. The analyses included 773 patients (407 mild; 366 moderate-to-severe). The percentage of patients reporting satisfaction with treatment was low overall, ranging from 8.6% to 61.7% for the mild and 13.9% to 49.5% for the moderate-to-severe group. Satisfaction among biologics users was also low (≤53%; 50% of satisfaction rates &lt;40%). Regression results consistently showed greater dissatisfaction with current treatment among moderately to severely affected patients. Many psoriasis patients were dissatisfied with their treatment; moderate-to-severe patients expressed significantly less satisfaction than mild patients.